Suppr超能文献

一种无载体的抗菌聚合物杂化金纳米颗粒作为协同治疗金黄色葡萄球菌感染伤口愈合的平台。

A Vehicle-Free Antimicrobial Polymer Hybrid Gold Nanoparticle as Synergistically Therapeutic Platforms for Staphylococcus aureus Infected Wound Healing.

机构信息

School of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.

Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325000, China.

出版信息

Adv Sci (Weinh). 2022 May;9(14):e2105223. doi: 10.1002/advs.202105223. Epub 2022 Mar 10.

Abstract

Pathogenic bacteria infection is a serious threat to human public health due to the high morbidity and mortality rates. Nano delivery system for delivering antibiotics provides an alternative option to improve the efficiency compared to conventional therapeutic agents. In addition to the drug loading capacity of nanocarriers, which is typically around 10%, further lowers the drug dose that pathological bacteria are exposed to. Moreover, nanocarriers that are not eliminated from the body may cause side effects. These limitations have motivated the development of self-delivery systems that are formed by the self-assembly of different therapeutic agents. In this study, a vehicle-free antimicrobial polymer polyhexamethylene biguanide (PHMB, with bactericidal and anti-biofilm functions) hybrid gold nanoparticle (Au NPs, with photothermal therapy (PTT)) platform (PHMB@Au NPs) is developed. This platform exhibits an excellent synergistic effect to enhance the photothermal bactericidal effect for Staphylococcus aureus under near-infrared irradiation. Furthermore, the results showed that PHMB@Au NPs inhibit the formation of biofilms, quickly remove bacteria to promote wound healing through PTT in infection model in vivo, and even mediate the transition of macrophages from M1 to M2 type, and accelerate tissue angiogenesis. PHMB@Au NPs will have promising value as highly effective antimicrobial agents for patient management.

摘要

病原细菌感染由于其高发病率和死亡率,对人类公共健康构成了严重威胁。与传统治疗剂相比,抗生素的纳米递药系统提供了提高效率的替代方案。除了纳米载体的载药能力通常约为 10%之外,这进一步降低了病理细菌暴露于药物的剂量。此外,未从体内消除的纳米载体可能会引起副作用。这些局限性促使人们开发了由不同治疗剂自组装形成的自递药系统。在本研究中,开发了一种无载体的抗菌聚合物聚六亚甲基双胍(PHMB,具有杀菌和抗生物膜功能)杂化金纳米颗粒(Au NPs,具有光热疗法(PTT)功能)平台(PHMB@Au NPs)。该平台在近红外辐射下表现出优异的协同作用,增强了对金黄色葡萄球菌的光热杀菌效果。此外,结果表明,PHMB@Au NPs 通过 PTT 抑制生物膜的形成,在体内感染模型中迅速去除细菌以促进伤口愈合,甚至介导巨噬细胞从 M1 型向 M2 型转变,并加速组织血管生成。PHMB@Au NPs 有望成为治疗患者的高效抗菌剂,具有很高的应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418d/9108595/ee49707799d4/ADVS-9-2105223-g006.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验